Document is current
Any future updates will be listed below
-
Authors
Tashiro, Ryota https://orcid.org/0000-0002-5543-408X
Kawazoe, Hitoshi https://orcid.org/0000-0002-0626-7908
Mamishin, Kanako
Seto, Keisuke
Udagawa, Ryoko
Saito, Yoshimasa
Hashimoto, Hironobu
Shimoi, Tatsunori
Yonemori, Kan
Yonemura, Masahito
Terakado, Hiroyuki
Nishimura, Takahiro
Kawasaki, Toshikatsu
Furukawa, Tetsuya
Nakamura, Tomonori
- License Information
-
More Information
Article History
Received: 17 April 2023
Accepted: 21 July 2023
First Online: 24 July 2023
Competing interests
: H.K. received research funding from Eli Lilly. K.M. received payment for presentations and expert testimony from Daiichi Sankyo and payment for presentations from Merck Serono. H.T. received research funding from AbbVie. T.N. received research funding from Chugai, Daiichi Sankyo, Kyowa Kirin, Otsuka Pharmaceutical, Sanofi, and Shionogi. The remaining authors have no relevant financial or non-financial interests to disclose. Moreover, the abovementioned funders had no role in the design, conduct, or reporting of this investigation. Thus, the authors have no actual conflicts of interest to declare.
